239 related articles for article (PubMed ID: 15606836)
21. Topical treatment of melanoma skin metastases with imiquimod: a review.
Sisti A; Sisti G; Oranges CM
Dermatol Online J; 2015 Feb; 21(2):. PubMed ID: 25756475
[TBL] [Abstract][Full Text] [Related]
22. Lentigo maligna (melanoma in situ) treated with imiquimod cream 5%: 12 case reports.
Spenny ML; Walford J; Werchniak AE; Beltrani V; Brennick JB; Storm CA; Perry AE; Chapman MS
Cutis; 2007 Feb; 79(2):149-52. PubMed ID: 17388218
[TBL] [Abstract][Full Text] [Related]
23. Imiquimod: a novel treatment for lentigo maligna.
Ahmed I; Berth-Jones J
Br J Dermatol; 2000 Oct; 143(4):843-5. PubMed ID: 11069469
[TBL] [Abstract][Full Text] [Related]
24. Local cryosurgery and imiquimod: A successful combination for the treatment of locoregional cutaneous metastasis of melanoma: A case series.
Rivas-Tolosa N; Ortiz-Brugués A; Toledo-Pastrana T; Baradad M; Traves V; Soriano V; Sanmartín V; Requena C; Martí R; Nagore E
J Dermatol; 2016 May; 43(5):553-6. PubMed ID: 26660713
[TBL] [Abstract][Full Text] [Related]
25. Imiquimod as an antiaging agent.
Metcalf S; Crowson AN; Naylor M; Haque R; Cornelison R
J Am Acad Dermatol; 2007 Mar; 56(3):422-5. PubMed ID: 17184874
[TBL] [Abstract][Full Text] [Related]
26. Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil.
Florin V; Desmedt E; Vercambre-Darras S; Mortier L
Invest New Drugs; 2012 Aug; 30(4):1641-5. PubMed ID: 21748297
[TBL] [Abstract][Full Text] [Related]
27. [Topical treatment of melanoma skin metastases with imiquimod].
Sigüenza M; Pizarro A; Mayor M; Vidaurrázaga C; Miralles L; González-Beato M; Casado M
Actas Dermosifiliogr; 2005 Mar; 96(2):111-5. PubMed ID: 16476347
[TBL] [Abstract][Full Text] [Related]
28. Treatment of lentigo maligna with imiquimod before staged excision.
Cotter MA; McKenna JK; Bowen GM
Dermatol Surg; 2008 Feb; 34(2):147-51. PubMed ID: 18093206
[TBL] [Abstract][Full Text] [Related]
29. Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks.
Quirk C; Gebauer K; Owens M; Stampone P
Australas J Dermatol; 2006 Nov; 47(4):258-65. PubMed ID: 17034468
[TBL] [Abstract][Full Text] [Related]
30. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe.
Schulze HJ; Cribier B; Requena L; Reifenberger J; Ferrándiz C; Garcia Diez A; Tebbs V; McRae S
Br J Dermatol; 2005 May; 152(5):939-47. PubMed ID: 15888150
[TBL] [Abstract][Full Text] [Related]
31. Imiquimod 5% cream for the treatment of nasal lesion of metastatic renal cell carcinoma.
Asakura M; Miura H
Dermatol Ther; 2011; 24(3):375-7. PubMed ID: 21689248
[TBL] [Abstract][Full Text] [Related]
32. Treatment of locally metastatic melanoma: a novel approach.
Shistik G; Prakash AV; Fenske NA; Glass LF
J Drugs Dermatol; 2007 Aug; 6(8):830-2. PubMed ID: 17763615
[TBL] [Abstract][Full Text] [Related]
33. Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease.
Fisher GH; Lang PG
Arch Dermatol; 2003 Jul; 139(7):945-7. PubMed ID: 12873904
[No Abstract] [Full Text] [Related]
34. Imiquimod cream 5% for the treatment of arsenic-induced cutaneous neoplasms.
Lonergan CL; McNamara EK; Cordoro KM; Greer KE
Cutis; 2010 Apr; 85(4):199-202. PubMed ID: 20486460
[TBL] [Abstract][Full Text] [Related]
35. Phase I/II study of topical imiquimod and intralesional interleukin-2 in the treatment of accessible metastases in malignant melanoma.
Green DS; Bodman-Smith MD; Dalgleish AG; Fischer MD
Br J Dermatol; 2007 Feb; 156(2):337-45. PubMed ID: 17223875
[TBL] [Abstract][Full Text] [Related]
36. Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head.
Stockfleth E; Sterry W; Carey-Yard M; Bichel J
Br J Dermatol; 2007 Dec; 157 Suppl 2():41-6. PubMed ID: 18067631
[TBL] [Abstract][Full Text] [Related]
37. Imiquimod 5% cream as a therapeutic option for extramammary Paget's disease.
Sawada M; Kato J; Yamashita T; Yoneta A; Hida T; Horimoto K; Sato S; Uhara H
J Dermatol; 2018 Feb; 45(2):216-219. PubMed ID: 29115681
[TBL] [Abstract][Full Text] [Related]
38. Twelve-week treatment of lentigo maligna with imiquimod results in a high and sustained clearance rate.
Kirtschig G; van Meurs T; van Doorn R
Acta Derm Venereol; 2015 Jan; 95(1):83-5. PubMed ID: 24696093
[TBL] [Abstract][Full Text] [Related]
39. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial.
Marks R; Gebauer K; Shumack S; Amies M; Bryden J; Fox TL; Owens ML;
J Am Acad Dermatol; 2001 May; 44(5):807-13. PubMed ID: 11312429
[TBL] [Abstract][Full Text] [Related]
40. Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage.
Neville JA; Williford PM; Jorizzo JL
J Drugs Dermatol; 2007 Sep; 6(9):910-4. PubMed ID: 17941362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
